Product Center
Hot Products
KIT’s 3ROCKIT 3R Center: Advancing Animal-Free Research for Personalized Medicine
December 1, 2024
In the future of medicine, personalized treatments could be guided by Virtual Human Twins, computer models designed to simulate individual patients. Today, methods to replace animal testing are already being developed, including human organ simulations on chips or in petri
Urinary Pentosidine as a Biomarker for Muscle Strength and Physical Performance in Young Men
November 29, 2024
A recent study reveals how urinary pentosidine, a simple biomarker, can offer valuable insights into muscle strength, bone health, and physical performance in young adults. This breakthrough has the potential to revolutionize health monitoring and pave the way for improved
Advanced Diagnostic Kit Developed for Detecting Highly Pathogenic H5N1 Avian Influenza Virus
November 27, 2024
Introduction: Collaborative Effort Yields Steadfast Diagnostic Kit The Diagnostics Development Hub (DxD Hub), a national platform hosted by the Agency for Science, Technology, and Research (A*STAR), Singapore, has successfully developed Steadfast, an advanced diagnostic kit for detecting the highly pathogenic
New Diagnostic Test Aims for Same-Day Detection of Leptomeningeal Disease
November 26, 2024
Groundbreaking Effort to Improve Early Detection and Treatment Monitoring UCLA researchers are developing a novel diagnostic test to detect the spread of cancer to the central nervous system on the same day as a doctor’s visit, addressing a critical need
CN Bio Launches PhysioMimix® Bioavailability Assay Kit: Human 18
November 22, 2024
Innovative Kit Enhances Drug Discovery with Predictive Human Bioavailability Insights [Cambridge, UK – November 2024] – CN Bio, a leading provider of Organ-on-a-Chip (OOC) systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its
Limited Impact of Prenatal COVID-19 Exposure on Child Neurodevelopmental Outcomes
November 21, 2024
Introduction A recent study published in JAMA Network Open has investigated the potential effects of prenatal exposure to COVID-19 on child neurodevelopment during the first two years of life. The study found only minor differences in infant regulatory behavior, but
New Biosensor Technology Could Revolutionize Mpox Diagnosis
November 16, 2024
A breakthrough in diagnostic technology could significantly impact the fight against mpox, a virus that has spread globally since 2022. Researchers from the University of California, San Diego (UCSD), and Boston University (BU) have developed an optical biosensor capable of
Diagnostic Toolkit Aims to Improve Response to Marburg Virus Cases
November 11, 2024
Viral hemorrhagic fevers (VHF) such as Marburg virus disease have recently gained attention due to outbreaks in various parts of the world. Recently, over 60 confirmed cases of Marburg have been reported in Rwanda. Although the risk of Marburg virus
New Diagnostic Test Promises Same-Day Detection of Leptomeningeal Disease
November 1, 2024
UCLA researchers are pioneering a groundbreaking diagnostic test aimed at achieving same-day detection of leptomeningeal disease (LMD), a serious complication that occurs when cancer spreads to the central nervous system. This rapid testing could prove crucial for patients facing dire
Blood Test Identifies Preeclampsia Risk in Laboring Women
October 31, 2024
A groundbreaking blood test may enable doctors to identify laboring women at risk for preeclampsia—a leading cause of maternal mortality—according to research presented at the ANESTHESIOLOGY® 2024 annual meeting. The Centers for Disease Control and Prevention (CDC) reports that between
New Grant to Develop Rapid Biosensors for African
October 30, 2024
Foreign animal diseases pose a significant threat to global swine production, with severe economic consequences. Researchers at the University of Illinois Urbana-Champaign have secured a three-year, $650,000 grant from the U.S. Department of Agriculture (USDA) to create sensitive, rapid, low-cost,
WHO Approves First Mpox In Vitro Diagnostic Test for Emergency Use
October 23, 2024
The World Health Organization (WHO) has made a significant advancement in global health by listing the Alinity m MPXV assay, manufactured by Abbott Molecular Inc., as the first mpox in vitro diagnostic (IVD) test under its Emergency Use Listing (EUL)